Take a Journey Through Biopharma Innovation with ZoomRx In Sight: Your Gateway to Expert Insights and Life Science Trends!
Welcome to the latest edition of ZoomRx In Sight, -- your essential gateway to the dynamic world of cutting-edge insights, breakthrough innovations, and industry trends. Dive into exclusive, expert analyses and updates on groundbreaking developments shaping the bio-pharmaceutical landscape. Stay informed, stay ahead. Welcome to a curated journey through the forefront of biopharma innovation – and be sure to become a subscriber to stay up to date on all things life science!
Unlocking Digital Success: Unveiling the Power of Share of Voice (SoV) with ZoomRx's PERxCEPT
Check out our new white paper where we explore Share of Voice (SoV) as a key metric for digital channels. We're thrilled to share how ZoomRx is making a difference by leveraging our extensive network of over 30,000 physicians and patients. We've developed an innovative, unbiased, and future-proof approach to measuring Digital SoV through our omnichannel intelligence tool, PERxCEPT.
Our white paper takes you through not only the importance of Digital SoV but also how PERxCEPT is revolutionizing its measurement. We've designed this methodology to be comprehensive and reliable, providing you with insights that truly matter.
Additionally, we delve into the various ways Digital SoV can be used to your advantage. By incorporating real-world examples, we aim to empower digital marketing teams like yours to make well-informed decisions. One highlight is a case study where PERxCEPT played a pivotal role in helping a marketing team successfully launch a new drug in a fiercely competitive market.
We hope this white paper serves as a valuable resource, shedding light on the potential of Digital SoV and how ZoomRx's PERxCEPT can be a game-changer for your marketing strategies. Feel free to explore and discover the exciting possibilities that lie ahead!
Enter your information below to instantly access the full white paper: link
Unveiling Insights: ZoomRx's Global Survey Explores Healthcare Provider Perceptions of Pharma Manufacturers
Healthcare providers (HCPs) play a pivotal role in guiding patient treatments through their prescribing and recommendations. Their views on pharmaceutical manufacturers and products hold significant weight. HCPs hesitate to endorse medications from biotech/pharmaceutical companies they perceive negatively.
ZoomRx is actively surveying over 1000 HCPs across 6 countries (US & EU5) to gain insights into their perspectives on pharmaceutical manufacturers. This comprehensive study explores both Industry Leaders & Challengers across 5 key therapeutic domains:
Read our previous report focused on perceptions in the US.
Recommended by LinkedIn
To learn more about the upcoming global manufacturer perception study, get in touch with Karni <karni.medh@zoomrx.com>. Stay tuned for the release of the ZoomRx Global Pharma Manufacturer Perception Study in September !!
Beyond General Purpose AI: Why ChatGPT Fails the Life Sciences Industry
AI technology holds immense promise to revolutionize the life sciences industry, but general purpose models like ChatGPT often fall short of meeting the specific needs of this sector.
We recently hosted a webinar to demonstrate how the life sciences industry can incorporate AI technology into their day-to-day workflows and address these challenges head-on.
In the session, we covered:
- The limitations of ChatGPT for life sciences professionals and how we can effectively address them.
- A live demonstration showcasing Ferma's vs ChatGPT's performance across a variety of life sciences-specific domains.
- A Q&A session to answer your queries about AI technology and its future.
You can view the 30-minute webinar here: watch now
Transforming Patient Experiences: Unveiling Insights from Real-World COPD and Asthma Appointments for Better Treatment Decisions
HCP-Pt Conversations for situational understanding
ZoomRx has used audio from unscripted, real-world clinical appointments to compare the patient experiences between COPD and Asthma. Biologic treatments are not yet available for COPD patients but much of the treatment discussions between the two indications share a lot of similarities. Below we look into some analogous situations from patients with COPD and Asthma and their doctors to see what we can learn from them. Learn more link